serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 3 (SERPINB3) ELISA Kits

May act as a protease inhibitor to modulate the host immune response against tumor cells.. Additionally we are shipping SERPINB3 Antibodies (123) and SERPINB3 Proteins (13) and many more products for this protein.

list all ELISA KIts Gene Name GeneID UniProt
SERPINB3 6317 P29508
Anti-Rat SERPINB3 SERPINB3 304688  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online


Showing 2 out of 6 products:

Catalog No. Reactivity Sensitivity Range Images Quantity Delivery Price Details
Human 27 pg/mL 78 pg/mL - 5000 pg/mL Typical standard curve SDS-PAGE of Protein Standard from the Kit (Highly purified E. coli-expressed recombinant human SERPINB3). 96 Tests 12 to 14 Days
Human 0.015 ng/mL n/a   96 Tests 11 to 16 Days

Top referenced SERPINB3 ELISA Kits

  1. Human SERPINB3 ELISA Kit for Sandwich ELISA - ABIN6574275 : Franciosi, Postma, van den Berge, Govorukhina, Horvatovich, Fusetti, Poolman, Lodewijk, Timens, Bischoff, ten Hacken: Susceptibility to COPD: differential proteomic profiling after acute smoking. in PLoS ONE 2014 (PubMed)

More ELISA Kits for SERPINB3 Interaction Partners

Human serpin Peptidase Inhibitor, Clade B (Ovalbumin), Member 3 (SERPINB3) interaction partners

  1. Concurrent elevation of preoperative SCC-Ag, CYFRA 21-1 and CRP serum levels can be correlated with worse survival rates in oral cavity squamous cell carcinoma.

  2. Results provide the first evidence that failure of serum SCCA to fall into the normal range by the fourth week of definitive radiotherapy is associated with significantly increased risk of recurrence and death.

  3. iron overload and was previously found capable of up-regulating SerpinB3 at the transcriptional level.

  4. the SCCA-IgM determination could be helpful in predicting the response to therapy in patients with hepatocellular carcinoma.

  5. Serum SCC-Ag, hs-CRP, and CA-125 were higher in recurrence cervical patients which could be potential biomarkers for predicting cervical cancer recurrence risk.

  6. A close connection between SerpinB3 and DPPPIV has been identified, but further studies are required to better understand the mechanism by which these proteins communicate and exert metabolic effects in hepatocellular carcinoma.

  7. Findings point to potential interest of squamous cell carcinoma antigen SERPINB3/B4 for the stratification of head and neck squamous cell carcinoma (HNSCC) patients in the therapeutic context.

  8. role of SERPINB3/B4 mutations in immunotherapy response

  9. Data show that in colorectal cancer SerpinB3, COX-2 and beta-Catenin are positively correlated and associated with more advanced tumor stage.

  10. Results showed no correlation between gestational age and vaginal fluid SCC levels. There was no significant difference in vaginal fluid SCC levels between patients with premature rupture of membranes and those with control pregnant women.

  11. Serum SCC-Ag level was an important predictor for the cervical squamous carcinoma recurrence and prognosis.

  12. Data indicate that serum tumor markers showed significant shorter 3-year progression-free survival (PFS) in higher levels compared to lower levels for S-CYFRA 21-1 (cytokeratin 19 fragment), S-SCCA and S-CEA.

  13. serum level is a reliable diagnostic marker to distinguish sinonasal inverted papilloma from inflammatory disease

  14. SerpinB3 indirectly increased the transcription of Myc through the induction of Yap pathway.

  15. Data show that serum neuron-specific enolase, cytokeratin 19 fragment 21-1, pro-gastrin-releasing peptide, squamous cell carcinoma antigen, tissue inhibitor of metalloproteinase-1, and human epididymis protein 4 are not associated with brain metastases.

  16. The diagnostic performance of SCCA-IgM immune complexes for hepatocellular carcinoma was found to be frequently superior to that of alpha-fetoprotein. (Review)

  17. High SCC serum levels are associated with Head and Neck Cancer.

  18. Data indicate that hypoxia-induced cysteine-proteases inhibitor SERPINB3 up-regulation is dependent on hypoxia-inducible factor-2alpha (HIF-2alpha).

  19. serum level significant risk factor for overall survival in cancers of the oral cavity, hypopharynx, and larynx

  20. High levels of neuron-specific enolase (NSE), carbohydrate antigen 125 (CA125) and squamous cell carcinoma antigen (SCC) were detected in 306 (63.6%), 89 (18.5%) and 125 (26.0%) non-small cell lung cancer patients, respectively.

SERPINB3 Antigen Profile

Antigen Summary

May act as a protease inhibitor to modulate the host immune response against tumor cells.

Gene names and symbols associated with SERPINB3

  • serpin family B member 3 (SERPINB3) antibody
  • serpin family B member 3 (Serpinb3) antibody
  • serpin B3 (LOC483954) antibody
  • Somatic cell count (SCC) antibody
  • HsT1196 antibody
  • SCC antibody
  • SCCA-1 antibody
  • SCCA-PD antibody
  • SCCA1 antibody
  • T4-A antibody

Protein level used designations for SERPINB3

protein T4-A , serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3 , serpin B3 , squamous cell carcinoma antigen 1 , serine protease inhibitor B3

6317 Homo sapiens
304688 Rattus norvegicus
483954 Canis lupus familiaris
Selected quality suppliers for SERPINB3 (SERPINB3) ELISA Kits
Did you look for something else?